- Home
- PHH
as 03-28-2025 4:00pm EST
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries specialize in providing skincare and cosmetic products under its brand name Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
| Founded: | 2016 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 160.1M | IPO Year: | 2024 |
| Target Price: | N/A | AVG Volume (30 days): | 465.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.02 | EPS Growth: | -43.83 |
| 52 Week Low/High: | $3.70 - $13.98 | Next Earning Date: | 01-01-0001 |
| Revenue: | $2,381,851 | Revenue Growth: | -3.14% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Park Ha Biological Technology Co. Ltd. Ordinary Shares News
PHH Breaking Stock News: Dive into PHH Ticker-Specific Updates for Smart Investing
Insider Monkey
4 days ago
Why Park Ha Biological Technology Co Ltd (PHH) Is Surging In 2025?
Insider Monkey
20 days ago
Why Park Ha Biological Technology Co., Ltd. (PHH) Soared Last Week
GlobeNewswire
3 months ago
D. Boral Capital Served as Underwriter to Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) in connection with its $4.8 Million Initial Public Offering
Compare PHH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.